首页 | 本学科首页   官方微博 | 高级检索  
检索        


Broad- and narrow-sense validity performance of three polygenic risk score methods for prostate cancer risk assessment
Authors:Hongjie Yu PhD  Zhuqing Shi PhD  Xiaoling Lin PhD  Quanwa Bao BD  Haifei Jia MD  Jun Wei PhD  Brian T Helfand MD  PhD  Siqun L Zheng MD  David Duggan PhD  Daru Lu PhD  Zengnan Mo PhD  Jianfeng Xu MD  DrPH
Institution:1. Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois;2. Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China;3. State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, China;4. Translational Genomics Research Institute, An Affiliate of City of Hope, Phoenix, Arizona;5. Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China
Abstract:
Keywords:clinical validity  genetic risk score  prostate cancer
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号